About Eclat Pharmaceuticals
Manufacturer of gasket sheets and sealing solutions. It provides a variety of gasket materials, including Tesnit, Doniflex, Grafilit, Doniflon, and Micalit sheets. The company also offers a range of gaskets, such as soft flat gaskets, semi-metallic gaskets, heat exchangers gaskets, metal gaskets, and PTFE-enveloped gaskets and machined products. Additional services include application engineering, training courses, and material selection assistance. A gasket calculation software is also available.
- Headquarter Missouri City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Avadel Pharmaceuticals
(Mar 14, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Eclat Pharmaceuticals
Detailed funding history for Eclat Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Eclat Pharmaceuticals
Eclat Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Avadel Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Proprietary drug delivery technologies and narcolepsy treatments are developed.
|
Locked | Locked | Locked |
Investor details for Eclat Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eclat Pharmaceuticals
Investment portfolio details for Eclat Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eclat Pharmaceuticals
Detailed financials for Eclat Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eclat Pharmaceuticals Comparisons
Peer comparison for Eclat Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eclat Pharmaceuticals
Detailed competitors of Eclat Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eclat Pharmaceuticals
Complete news archive for Eclat Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eclat Pharmaceuticals
Eclat Pharmaceuticals was founded in 2010.
Eclat Pharmaceuticals is headquartered in Missouri City, United States. It is registered at Missouri City, Texas, United States.
Manufacturer of gasket sheets and sealing solutions. It provides a variety of gasket materials, including Tesnit, Doniflex, Grafilit, Doniflon, and Micalit sheets. The company also offers a range of gaskets, such as soft flat gaskets, semi-metallic gaskets, heat exchangers gaskets, metal gaskets, and PTFE-enveloped gaskets and machined products. Additional services include application engineering, training courses, and material selection assistance. A gasket calculation software is also available.
Eclat Pharmaceuticals has 1 investor. Key investors include Avadel Pharmaceuticals.